025sek
-7,4 %
Date:2025-12-08Time:18:00:00Latest report:Q3-2025List:SpotlightTicker:PEXA B
Market Cap:31 msekEnterprise Value:23 msekNet Sales:0,82 msekEarnings:-10,1 msekEmployees:0ISIN:SE0007412374

Ratios

10-year key figure history for PExA turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for PExA with index and moving average MA50 and MA200.

Stockprice:0,25
MA50:0,22
MA200:0,22
Price/MA200:12,3 %
RSI (14):51,7
Price/MA50:12,4 %

Description

PExA offers a patented, non-invasive technology to collect biomarkers from the small airways of the lung via exhaled air. The method is used globally by universities, hospitals, pharmaceutical companies, CROs and government agencies in the US and Europe, among others – in research on asthma, COPD, lung cancer, occupational exposure and pharmacokinetics. The company's goal is to enable earlier diagnosis and screening of lung diseases. PExA was founded in 2014 and is headquartered in Gothenburg.

Medical Equipment